Modified personalized cancer vaccine generates powerful immune response

Published Date: 11 Jul 2025

Results of a Dana-Farber Cancer Institute-initiated phase 1 clinical trial for patients with melanoma show that an updated formula and delivery of the NeoVax personalized cancer vaccine called NeoVaxMI is safe, feasible, ...

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

AI tool accurately detects tumor location on breast MRI

2.

Month-Long Wait Times Caused by US Physician Shortage.

3.

Hereditary cancer has a rare and underreported cause.

4.

Transplantation Fails to Improve Survival in Mantle Cell Lymphoma

5.

Scientists develop scans that light up aggressive cancer tumors for better treatment


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot